Abbvie Inc

NYSE:ABBV   3:59:57 PM EDT
108.58
-0.56 (-0.51%)
Products

U.S. FDA Accepts Abbvie's New Drug Application For Atogepant For The Preventive Treatment Of Migraine

Published: 03/30/2021 12:29 GMT
Abbvie Inc (ABBV) - U.S. FDA Accepts Abbvie's New Drug Application for Atogepant for the Preventive Treatment of Migraine.